Monitor for actual Form 4 filings to confirm if and when the sale occurs. Given the small size relative to market cap and the ongoing 10b5-1 plan context, this notice alone is unlikely to move the stock. However, continued insider selling could signal reduced confidence.
Price Chart
Executive Summary
Roger Jeffs, a director and officer of Liquidia Corp, filed a Form 144 to sell up to 24,733 shares of common stock, valued at approximately $132,000. The sale is part of a 10b5-1 plan for Serendipity Biopharma LLC, an entity affiliated with Jeffs. This filing is an advance notice and does not confirm the sale has occurred.
Key Facts
- Roger Jeffs, Director and Officer of Liquidia Corp, is the reporting owner.
- Form 144 filed for 24,733 shares of common stock, with an estimated value of $132,000.
- Sale is conducted under a 10b5-1 plan for Serendipity Biopharma LLC, an affiliated entity.
- No actual sale has occurred yet; this is a notice of proposed sale.
- Recent insider selling activity includes $3.9M in sales over the past 30 days.
Financial Impact
Approximately $132,000 in potential stock sale, representing a small fraction of Liquidia's $3.4B market cap.
Risk Factors
- Perception of insider selling may negatively influence investor sentiment, especially amid recent $3.9M in insider outflows.
- If sales proceed near-term, increased supply could pressure the stock price, particularly in low-volume trading environments.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 144 Filing (Primary) | 0001950047-26-003494 |
| Document: 0001950047-26-003494-index.html | 0001950047-26-003494 |
| Document: 0001950047-26-003494.txt | 0001950047-26-003494 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 13, 2026 12d ago | 8-K | $33.94 $34.78 | ▲ +2.48% | ▲ +2.19% | $43.74 (+28.87%) |
Oct 13, 2026 12d ago | Insider Cluster | $33.94 $34.78 | ▲ +2.48% | ▲ +2.19% | $43.74 (+28.87%) |
Sep 30, 2026 25d ago | 8-K | $27.99 $28.64 | ▼ −2.32% | ▼ −1.58% | $43.74 (−56.27%) |
Sep 3, 2026 7w ago | 8-K | $68.63 $68.66 | ▲ +0.04% | ▲ +0.43% | $43.74 (−36.27%) |
Sep 3, 2026 7w ago | Press Release | $68.63 $68.66 | ▲ +0.04% | ▲ +0.43% | $43.74 (−36.27%) |
Aug 25, 2026 8w ago | Insider Cluster | $71.36 $69.94 | ▼ −1.99% | ▼ −2.65% | $43.74 (−38.71%) |
Aug 21, 2026 9w ago | Insider Cluster | $70.27 $70.49 | ▲ +0.31% | ▼ −0.01% | $43.74 (−37.75%) |
Aug 12, 2026 10w ago | 8-K | $78.79 $72.10 | ▼ −8.49% | ▼ −9.19% | $43.74 (−44.49%) |
Aug 12, 2026 10w ago | Press Release | $78.79 $72.10 | ▲ +8.49% | ▲ +9.19% | $43.74 (+44.49%) |
Jul 29, 2026 12w ago | Insider Cluster | $86.80 $84.11 | ▼ −3.10% | ▼ −3.82% | $43.74 (−49.61%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers